A board-certified Internal Medicine professional with 20 years of clinical research experience across all phases of drug development. Currently the medical lead for early development strategy from translational medicine to study design and clinical conduct. >680 studies as Principal Investigator and still active in an investigator role for complex studies. Primary focus is first-in-human and first-in-patient 1b programs. Successful with multiple indications and patient populations.